{"id":"W1590209850","doi":"10.1111/j.1464-410x.2010.09687.x","title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1‐year, open‐label extension study","year":2011,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"St Joseph's Health Care","funders":"Eli Lilly and Company","keywords":"Tadalafil; Medicine; Lower urinary tract symptoms; Erectile dysfunction; Placebo; Adverse effect; Vardenafil; cGMP-specific phosphodiesterase type 5; Urology; Urinary system; Benign prostatic hyperplasia (BPH); Internal medicine; Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006874519,0.001750629,0.00504642,0.0006909931,0.001033465,0.001273906,0.001299995,0.002173374,0.005370263],"category_scores_gemma":[0.003360071,0.001116943,0.004220403,0.0009071901,0.00138041,0.001585546,0.0006375554,0.003125678,0.001430161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007837453,"about_ca_system_score_gemma":0.002145719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001733386,"about_ca_topic_score_gemma":0.001868585,"domain_scores_codex":[0.9971944,0.00132923,0.0002683887,0.0004317668,0.0004726249,0.0003034438],"domain_scores_gemma":[0.9959668,0.0007975392,0.0009863304,0.000686068,0.0005501275,0.001013233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9055492,0.05166139,0.011739,0.001245303,0.004541823,0.0001613094,0.0002271198,0.0002654692,0.004238681,0.00006297453,0.001059959,0.01924778],"study_design_scores_gemma":[0.576884,0.371975,0.045458,0.0001283739,0.002801124,0.000114399,0.00007729247,0.0003023261,0.0007894447,0.00008632356,0.001330286,0.00005336602],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820439,0.004604851,0.0007282178,0.0002103228,0.0003425784,0.008242493,0.00231497,0.00008023405,0.001432442],"genre_scores_gemma":[0.9782556,0.00358411,0.001464954,0.0009806126,0.0009640036,0.007921697,0.003852734,0.00002423976,0.002952044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006874519,"threshold_uncertainty_score":0.03635633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07549948486873817,"score_gpt":0.3487924495858137,"score_spread":0.2732929647170755,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}